Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, United States.
Diabetes Res Clin Pract. 2013 Jun;100(3):362-7. doi: 10.1016/j.diabres.2013.03.018. Epub 2013 Apr 6.
In type 2 diabetes, early effects of strict near-normalization of glucose control on macrovascular and microvascular disease are still uncertain. We evaluated the effects of early dramatic improvement in glycemia on retinal disease in poorly controlled diabetes.
A retrospective, case-control study in public hospital patients with type 2 diabetes, who had annual retinal imaging as part of a case management program or standard diabetes care. Patients included had ≥2 two retinal images ≥1 one year apart, and at least 3 HbA1C measurements. Retinal images were graded using a modified Scottish Diabetic Retinopathy grading scheme. An 'intensive' group (n=34) with HbA1C decrease >1.5% was compared with randomly chosen patients (n=34) with minimal HbA1C changes.
Mean HbA1C (±SEM) over two years was similar in intensive (8.5 ± 0.21%) and control groups (8.1 ± 0.28%, p=NS). However, the intensive group had higher baseline HbA1C and a mean maximal decrease of 4.0 ± 0.41% in contrast to the control group (0.2 ± 0.11%). Retinopathy grade progressed +0.7 ± 0.25 units from baseline in the intensive group (p=0.015), a 22.6% worsening. The control group changed minimally from baseline (0.03 ± 0.14 units, p=NS). Change in retinopathy grade was significantly different between groups (p=0.02). More eyes worsened by ≥ 1 retinal grade (p=0.0025) and developed sight-threatening retinopathy (p=0.003) in the intensive group. Visual acuity was unchanged.
Diabetic retinopathy significantly worsened in poorly controlled type 2 diabetes after early intensification of glycemic control and dramatic HbA1C change. Retinal status should be part of risk-factor evaluation in patients likely to experience marked reductions in HbA1C in poorly controlled diabetes.
在 2 型糖尿病中,严格将血糖控制在接近正常水平对大血管和微血管疾病的早期影响仍不确定。我们评估了早期血糖显著改善对控制不佳的糖尿病视网膜病变的影响。
这是一项回顾性的、病例对照研究,纳入了公立医院的 2 型糖尿病患者,这些患者的年度视网膜成像作为病例管理计划或标准糖尿病护理的一部分。患者至少有 3 次糖化血红蛋白(HbA1C)测量值,且至少有 2 次视网膜图像相隔一年以上。视网膜图像使用改良的苏格兰糖尿病视网膜病变分级方案进行分级。将 HbA1C 下降>1.5%的“强化”组(n=34)与 HbA1C 变化最小的随机选择的患者(n=34)进行比较。
强化组(8.5 ± 0.21%)和对照组(8.1 ± 0.28%)两年内的平均 HbA1C(±SEM)相似(p=NS)。然而,强化组的基线 HbA1C 较高,最大平均降幅为 4.0 ± 0.41%,而对照组为 0.2 ± 0.11%。强化组的视网膜病变分级较基线增加+0.7 ± 0.25 单位(p=0.015),恶化 22.6%。对照组的基线变化很小(0.03 ± 0.14 单位,p=NS)。两组之间的视网膜病变分级变化差异有统计学意义(p=0.02)。强化组更多的眼睛恶化≥1 个视网膜分级(p=0.0025)并发生威胁视力的视网膜病变(p=0.003)。视力无变化。
在血糖控制不佳的 2 型糖尿病患者中,早期强化血糖控制和 HbA1C 急剧下降会导致糖尿病视网膜病变显著恶化。在血糖控制不佳的糖尿病患者中,HbA1C 明显降低的情况下,视网膜状况应作为危险因素评估的一部分。